Cefprozil

Chemical formula: C₁₈H₁₉N₃O₅S  Molecular mass: 389.426 g/mol  PubChem compound: 5281006

Interactions

Cefprozil interacts in the following cases:

Severe renal impairment

For those with creatinine clearance values ≤30 ml/min, 50% of the standard dose should be given at the standard dosing interval. Cefprozil is in part removed by hemodialysis; therefore, cefprozil should be administered after the completion of hemodialysis.

Diuretics

Cephalosporins, including cefprozil, should be given with caution to patients receiving concurrent treatment with potent diuretics since these agents are suspected of adversely affecting renal function.

Aminoglycosides

Concomitant administration of cefprozil and aminoglycoside antibiotics causes nephrotoxicity.

Probenecid

Coadministration of cefprozil with probenecid doubles the area under the curve (AUC) of cefprozil.

Pregnancy

Safety of use in pregnancy has not been established.

Nursing mothers

Safety of use in lactation has not been established.

Effects on ability to drive and use machines

Cefprozil may cause dizziness which may affect ability to drive or use machinery. These activities should not be performed until the influence of cefprozil on the individual has been determined.

Adverse reactions


Blood and the lymphatic system disorders

Frequent: Eosinophilia.

Less frequent: Neutropenia, thrombocytopenia. Prolonged PT/INR has been observed.

Immune system disorders

Less frequent: Anaphylaxis, fever, serum sickness and pseudomembranous colitis.

Frequency unknown: Angioedema

Nervous system disorders

The following side effects have been reported and frequencies are unknown: Dizziness, hyperactivity, headache, nervousness, insomnia, confusion and somnolence.

Gastrointestinal disorders

Frequent: Nausea, vomiting, diarrhoea and abdominal pain.

Hepato-biliary disorders

Less frequent: Cholestatic jaundice.

The following side effects have been reported and frequencies are unknown: Elevations of AST, ALT, alkaline phosphatase, bilirubin values.

Skin and subcutaneous tissue disorders

Less frequent: Erythema multiforme, Stevens-Johnson syndrome, superinfection, rash, urticaria.

Renal and urinary disorders

The following side effects have been reported and frequencies are unknown: Elevations in blood urea and serum creatinine.

Reproductive system and breast disorders

Less frequent: General pruritus and vaginitis.

Cross-check medications

Review your medication to ensure that there are no potentially harmful drug interactions or contraindications.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.